Som Biotech

Developer of platform for screening compounds to treat rare diseases

placeBarcelona, Catalonia, Spain calendar_todayFounded 2009 groups15 employees language sombiotech.com

Social engagement

Social engagement: 5.6K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include European Investment Bank, Prevail Partners.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%

Recent activity

15 May 2026
Event
2026 Huntington's Disease Society of America 41st Annual Convention
13 Dec 2025
Event
Hawington's Disease webinar
21 Oct 2025
Milestone
regulatory
Coming soon